Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly ...

The chip maker posted a big jump in revenue in its data-center business, but the results undershot analysts' r ...

Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

The Nasdaq and other major stock market indexes dipped Wednesday after underwhelming earnings reports from Google parent ...

As we mentioned on Tuesday, the majority of companies on the S&P 500 that have reported earnings, have beaten estimates, and ...

To access PowerToys settings, tools, and info, click its icon in the notification area at the right-hand side of the Windows ...

That explains, in part, why the portfolio has spent time in the large-growth area of the Morningstar Style Box before tacking ... has about 100 holdings and 2%-4% of assets in each of its top ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

Congressional representatives push to ease regulatory hurdles for de novo banks, citing barriers to entry for small lenders.